⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 6, 1996JNCI Journal of the National Cancer Institute

Tamoxifen Induction of Apoptosis in Estrogen Receptor-Negative Cancers: New Tricks for an Old Dog?

Edward P. Gelmann

View at Publisher

Ask AI

Bookmark

Share

Abstract

Edward P. Gelmann; Tamoxifen Induction of Apoptosis in Estrogen Receptor-Negative Cancers: New Tricks for an Old Dog?, JNCI: Journal of the National Cancer

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Edward P. Gelmann (1996) studied this question.

synapsesocial.com/papers/6aae5220cf9fbefbfb1c21bc https://doi.org/10.1093/jnci/88.5.224

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Novel framework for the validation of intermediate clinical endpoints in oncology real-world dataJNCI Journal of the National Cancer Institute · Mon,
2Effects of private health insurance coverage gains on colorectal cancer outcomes: a modeling studyJNCI Journal of the National Cancer Institute · Mon,
3Identification of prediagnostic proteomic biomarkers for colon and rectal cancer in 3 prospective cohortsJNCI Journal of the National Cancer Institute · Mon,
4Time trends of human papillomavirus-attributable head and neck cancers: the BROADEN studyJNCI Journal of the National Cancer Institute · Mon,
5Colonoscopy screening outcomes in Lynch syndrome and differential colorectal cancer paths among MLH1 / MSH2 carriersJNCI Journal of the National Cancer Institute · Mon,

More from JNCI Journal of the National Cancer Institute

Cardio-protection and monitoring for early phase clinical trials: Recommendations from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortiumMon,
Claims-based frailty, dual eligibility, and potential unmet home-health needs in older breast cancer survivorsMon,
Lifestyle and genetic risk factors for postmenopausal breast cancer in the multiethnic cohortWed,
Alignment with lifestyle recommendations and physical health in breast cancer survivors and women without cancerTue,
Trends in bone health agent use and skeletal events in metastatic castration-resistant prostate cancerMon,